Lavo Life Sciences offers AI-powered crystal structure prediction to streamline drug development. By combining computational chemistry expertise with advanced AI, Lavo helps pharmaceutical teams de-risk pipelines, optimize solid-state formulations, and avoid late-stage surprises. This cutting-edge solution enables faster crystal form identification and improves drug stability and manufacturability.
Key Features:
- Accurate crystal structure prediction for small molecule drugs.
- AI-accelerated identification of novel polymorphs with enhanced properties.
- Reduced risk of unexpected crystal forms disrupting drug development.
- Optimization of solid-state formulations for stability and production.
- Faster turnaround for crystal form identification and analysis.
Disclaimer: Please refer to the website for the most accurate and current pricing details and service offerings.
Best for:
- Drug developers aiming to minimize risks in formulation design.
- Pharmaceutical teams looking to accelerate solid-state research.
- Companies seeking to optimize drug stability and manufacturability.
- Researchers exploring novel polymorphs with unique properties.
- Teams wanting to reduce time spent on crystal form identification.
- Organizations prioritizing AI-driven insights for better decision-making.
- Professionals focusing on de-risking pipelines for smooth drug development.
Try now